Patents by Inventor Kana Suzuki

Kana Suzuki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230023463
    Abstract: According to the present invention, a composition that has high safety, can be continuously used for a long period, promotes production of VEGF and FGF7 involved in hair growth, and affords good prophylactic or improving effect on thinning hair or hair loss can be provided.
    Type: Application
    Filed: September 22, 2022
    Publication date: January 26, 2023
    Applicant: AJINOMOTO CO., INC.
    Inventors: Yukino Katayama, Kana Suzuki, Katsuya Suzuki, Chie Tanaka, Yoshinobu Takino, Yasuyo Suga, Reiko Ichikawa, Shinobu Akiyoshi
  • Patent number: 11137401
    Abstract: The present invention relates to a method for detecting cancer, comprising measuring the expression of a polypeptide having a reactivity of binding to an antibody against a CAPRIN-1 protein having an amino acid sequence shown in any one of the even-numbered SEQ ID NOS: 2-30 in the Sequence Listing via an antigen-antibody reaction in a sample separated from a living organism, and, a reagent for detecting a cancer comprising the CAPRIN-1 protein or a fragment thereof, an antibody against the CAPRIN-1 protein or a fragment thereof, or a polynucleotide encoding the CAPRIN-1 protein or a fragment thereof.
    Type: Grant
    Filed: August 5, 2009
    Date of Patent: October 5, 2021
    Assignee: TORAY INDUSTRIES, INC.
    Inventors: Fumiyoshi Okano, Kana Suzuki
  • Publication number: 20210047691
    Abstract: An embodiment according to the present invention provides a kit or device for detection of dementia, and a method for detecting dementia. An embodiment according to the present invention relates to: a kit or device for detection of dementia, including a nucleic acid(s) capable of specifically binding to an miRNA(s) or a complementary strand(s) thereof in a sample from a subject; and a method for detecting dementia, including measuring the miRNA(s) in vitro.
    Type: Application
    Filed: February 12, 2019
    Publication date: February 18, 2021
    Applicants: TORAY INDUSTRIES, INC., NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY
    Inventors: Kana SUZUKI, Makiko YOSHIMOTO, Junpei KAWAUCHI, Hiroko SUDO, Yuho KIDA, Satoko KOZONO, Satoshi KONDOU, Shumpei NIIDA, Yuya ASANOMI, Daichi SHIGEMIZU, Takashi SAKURAI
  • Patent number: 10354803
    Abstract: A device includes a capacitor that has first and second electrodes having a capacitor insulator there-between. The first electrode is elongated and extends elevationally. The first electrode has elevationally-extending first conductive material and has second conductive material that projects laterally outward from an elevationally-extending part of the first conductive material. The laterally-projecting second conductive material has a vertical thickness that is less than that of the elevationally-extending first conductive material. Support material laterally supports the capacitor and contacts a tip end of the laterally-projecting second conductive material.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: July 16, 2019
    Assignee: Micron Technology, Inc.
    Inventors: Kenji Komeda, Kana Suzuki
  • Publication number: 20190148078
    Abstract: A device includes a capacitor that has first and second electrodes having a capacitor insulator there-between. The first electrode is elongated and extends elevationally. The first electrode has elevationally-extending first conductive material and has second conductive material that projects laterally outward from an elevationally-extending part of the first conductive material. The laterally-projecting second conductive material has a vertical thickness that is less than that of the elevationally-extending first conductive material. Support material laterally supports the capacitor and contacts a tip end of the laterally-projecting second conductive material.
    Type: Application
    Filed: January 15, 2019
    Publication date: May 16, 2019
    Applicant: Micron Technology, Inc.
    Inventors: Kenji Komeda, Kana Suzuki
  • Patent number: 10217569
    Abstract: A device includes a capacitor that has first and second electrodes having a capacitor insulator there-between. The first electrode is elongated and extends elevationally. The first electrode has elevationally-extending first conductive material and has second conductive material that projects laterally outward from an elevationally-extending part of the first conductive material. The laterally-projecting second conductive material has a vertical thickness that is less than that of the elevationally-extending first conductive material. Support material laterally supports the capacitor and contacts a tip end of the laterally-projecting second conductive material.
    Type: Grant
    Filed: October 18, 2016
    Date of Patent: February 26, 2019
    Assignee: Micron Technology, Inc.
    Inventors: Kenji Komeda, Kana Suzuki
  • Publication number: 20180108486
    Abstract: A device comprises a capacitor comprising first and second electrodes having a capacitor insulator there-between. The first electrode is elongated and extends elevationally. The first electrode comprises elevationally-extending first conductive material and comprises second conductive material that projects laterally outward from an elevationally-extending part of the first conductive material. The laterally-projecting second conductive material has a vertical thickness that is less than that of the elevationally-extending first conductive material. Support material laterally supports the capacitor and contacts a tip end of the laterally-projecting second conductive material.
    Type: Application
    Filed: October 18, 2016
    Publication date: April 19, 2018
    Inventors: Kenji KOMEDA, Kana Suzuki
  • Patent number: 9249409
    Abstract: A method for detecting a cancer(s) based on an expression of prescribed polypeptides is disclosed. These polypeptides were isolated, by the SEREX method using a cDNA library derived from canine testis and serum from a cancer-bearing dog, as a polypeptide which binds to an antibody existing in serum derived from cancer-bearing living body. Because these polypeptides react with antibodies specifically existing in serum of a cancer patient, cancers in a living body can be detected by measuring the antibody in a sample. Cancers in a living body can also be detected by measuring the antigen protein of the antibody per se or mRNA encoding it.
    Type: Grant
    Filed: October 23, 2008
    Date of Patent: February 2, 2016
    Assignee: TORAY INDUSTRIES, INC.
    Inventors: Fumiyoshi Okano, Kana Suzuki
  • Publication number: 20110136121
    Abstract: The present invention relates to a method for detecting cancer, comprising measuring the expression of a polypeptide having a reactivity of binding to an antibody against a CAPRIN-1 protein having an amino acid sequence shown in any one of the even-numbered SEQ ID NOS: 2-30 in the Sequence Listing via an antigen-antibody reaction in a sample separated from a living organism, and, a reagent for detecting a cancer comprising the CAPRIN-1 protein or a fragment thereof, an antibody against the CAPRIN-1 protein or a fragment thereof, or a polynucleotide encoding the CAPRIN-1 protein or a fragment thereof.
    Type: Application
    Filed: August 5, 2009
    Publication date: June 9, 2011
    Inventors: Fumiyoshi Okano, Kana Suzuki
  • Publication number: 20100297646
    Abstract: A method for detecting a cancer(s) based on an expression of prescribed polypeptides is disclosed. These polypeptides were isolated, by the SEREX method using a cDNA library derived from canine testis and serum from a cancer-bearing dog, as a polypeptide which binds to an antibody existing in serum derived from cancer-bearing living body. Because these polypeptides react with antibodies specifically existing in serum of a cancer patient, cancers in a living body can be detected by measuring the antibody in a sample. Cancers in a living body can also be detected by measuring the antigen protein of the antibody per se or mRNA encoding it.
    Type: Application
    Filed: October 23, 2008
    Publication date: November 25, 2010
    Inventors: Fumiyoshi Okano, Kana Suzuki